PubMed ID:
37357351
Public Release Type:
Journal
Publication Year: 2023
Affiliation: Division of Nephrology, Department of Medicine, School of Medicine, University of California, San Francisco, San Francisco, CA, United States.; Division of Nephrology, Department of Medicine, School of Medicine, University of California, San Francisco, San Francisco, CA, United States.; Division of Nephrology, Department of Medicine, School of Medicine, University of California, San Francisco, San Francisco, CA, United States.; Department of Physiological Nursing, School of Nursing, University of California, San Francisco, San Francisco, CA, United States.; Kidney Medicine Section, Medical Service, VA Pittsburgh Healthcare System, Pittsburgh, PA, United States.; Center for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United States.; Division of Nephrology, Hennepin Healthcare and University of Minnesota, Minneapolis, MN, United States.; Department of Physiological Nursing, School of Nursing, University of California, San Francisco, San Francisco, CA, United States.
DOI:
https://doi.org/10.34067/KID.0000000000000201
Authors:
Kwong Yuenting D, Liu Kathleen D, Hsu Chi-Yuan, Cooper Bruce, Palevsky Paul M, Kellum John A, Johansen Kirsten L, Miaskowski Christine
Request IDs:
21611
Studies:
Acute Renal Failure Trial Network
A large amount of inter-individual variability exists in health-related quality of life outcomes following acute kidney injury (AKI). This study aimed to determine if subgroups of early AKI survivors could be identified based on distinct health utility impairment profiles ascertained at 60 days after AKI and if these subgroups differed in clinical and biomarker characteristics at index hospitalization and outcomes at 1-year follow up.